Literature DB >> 25400762

Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol.

Chunyan Zhu1, Ping Xie2, Fei Zhao1, Lingqiang Zhang2, Wei An3, Yutao Zhan1.   

Abstract

The role of cholesterol in the pathogenesis of non-alcoholic steatohepatitis (NASH) remains unclear. It is known that apoptosis of hepatocytes is an important characteristics of NASH. The objective of this study was to investigate the effects of cholesterol on steatotic HepG2 cell apoptosis and the possible mechanism in vitro. In this study, HepG2 cells were divided into three groups: (1) normal group, (2) steatosis group and (3) cholesterol group. HepG2 cells were treated with oleic acid to establish a steatosis study model. Steatosis was assessed by Oil Red O staining and triglyceride content assay. Cell apoptosis was measured using an apoptosis kit. The expression levels of apoptosis-related proteins (P53, Bcl-2, Bax, caspase-3, cyclin A, cyclin B1 and cyclin E) were determined by western blot analyses. We found that a hepatocyte steatosis model was successfully established by oleic acid (200 μmol/L) induction. The cholesterol (50 mg/L) group had similar amount of lipid droplets and triglyceride content as steatosis group (P > 0.5). However, the apoptosis rate (P < 0.01) of the cholesterol group was significantly higher than that of the normal group or the steatosis group, and the protein expressions of Bax and caspase-3, but not P53, Bcl-2, cyclin A, cyclin B1 and cyclin E, were also increased in the cholesterol group. Those results suggested that cholesterol markedly promoted apoptosis of steatosis HepG2 cells in vitro, likely through the up-regulation of Bax and caspase-3 expression. This study contributes to explain the effect of cholesterol on NASH pathogenesis.

Entities:  

Keywords:  Cholesterol; HepG 2 cells; apoptosis; steatosis

Mesh:

Substances:

Year:  2014        PMID: 25400762      PMCID: PMC4230101     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.

Authors:  Lay T Gan; Derrick M Van Rooyen; Mark E Koina; Robert S McCuskey; Narcissus C Teoh; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2014-07-24       Impact factor: 25.083

Review 2.  Evolving therapies for non-alcoholic steatohepatitis.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Expert Opin Drug Discov       Date:  2014-04-25       Impact factor: 6.098

3.  Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.

Authors:  George K Anagnostopoulos; Dimitrios Stefanou; Evdokia Arkoumani; George Sakorafas; George Pavlakis; Dimitrios Arvanitidis; Epameinondas Tsianos; Niki J Agnantis
Journal:  J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 4.029

Review 4.  Apoptosis in alcoholic and nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Gregory J Gores
Journal:  Front Biosci       Date:  2005-09-01

Review 5.  Novel insights into the pathophysiology of nonalcoholic fatty liver disease.

Authors:  Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

6.  Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.

Authors:  Savitha Subramanian; Leela Goodspeed; Shari Wang; Jinkyu Kim; Lixia Zeng; George N Ioannou; W Geoffrey Haigh; Matthew M Yeh; Kris V Kowdley; Kevin D O'Brien; Subramaniam Pennathur; Alan Chait
Journal:  J Lipid Res       Date:  2011-06-20       Impact factor: 5.922

7.  Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways.

Authors:  Hirohito Yamaguchi; Jiandong Chen; Kapil Bhalla; Hong-Gang Wang
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

8.  Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells.

Authors:  Yunwei Ou; Liying Ma; Ling Ma; Zhen Huang; Wei Zhou; Chunling Zhao; Bailin Zhang; Yongmei Song; Chunjiang Yu; Qimin Zhan
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

9.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Ashwani Kapoor; Michael Fuchs; Faridoddin Mirshahi; Huiping Zhou; James Maher; John Kellum; Russell Warnick; Melissa J Contos; Arun J Sanyal
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats.

Authors:  Zheng-Jie Xu; Jian-Gao Fan; Xiao-Dong Ding; Liang Qiao; Guo-Liang Wang
Journal:  Dig Dis Sci       Date:  2009-05-21       Impact factor: 3.199

View more
  11 in total

Review 1.  Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Pharmaceut Med       Date:  2019-12

Review 2.  Glycosyltransferases and non-alcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Hai-Ying Su; Wei An
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

3.  ER stress related factor ATF6 and caspase-12 trigger apoptosis in neonatal hypoxic-ischemic encephalopathy.

Authors:  Luran Liu; Chang Liu; Yuting Lu; Lina Liu; Yan Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Optimized Rapeseed Oils Rich in Endogenous Micronutrients Protect High Fat Diet Fed Rats from Hepatic Lipid Accumulation and Oxidative Stress.

Authors:  Jiqu Xu; Xiaoli Liu; Hui Gao; Chang Chen; Qianchun Deng; Qingde Huang; Zhonghua Ma; Fenghong Huang
Journal:  Nutrients       Date:  2015-10-14       Impact factor: 5.717

5.  Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.

Authors:  Lijun Pang; Kai Liu; Daojie Liu; Fudong Lv; Yunjin Zang; Fang Xie; Jiming Yin; Ying Shi; Yanjun Wang; Dexi Chen
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

6.  Ethanol extract of Allium fistulosum inhibits development of non-alcoholic fatty liver disease.

Authors:  Jin-Taek Hwang; Eun Ju Shin; Min-Yu Chung; Jae Ho Park; Sangwon Chung; Hyo-Kyoung Choi
Journal:  Nutr Res Pract       Date:  2018-03-22       Impact factor: 1.926

7.  Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathway.

Authors:  Suryakant Niture; Maxwell A Gyamfi; Habib Kedir; Elena Arthur; Habtom Ressom; Gagan Deep; Deepak Kumar
Journal:  Cell Commun Signal       Date:  2018-11-08       Impact factor: 5.712

Review 8.  Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach.

Authors:  Natalia Nuño-Lámbarri; Varenka J Barbero-Becerra; Misael Uribe; Norberto C Chávez-Tapia
Journal:  Int J Mol Sci       Date:  2016-03-15       Impact factor: 5.923

Review 9.  Apoptosis and non-alcoholic fatty liver diseases.

Authors:  Tatsuo Kanda; Shunichi Matsuoka; Motomi Yamazaki; Toshikatsu Shibata; Kazushige Nirei; Hiroshi Takahashi; Tomohiro Kaneko; Mariko Fujisawa; Teruhisa Higuchi; Hitomi Nakamura; Naoki Matsumoto; Hiroaki Yamagami; Masahiro Ogawa; Hiroo Imazu; Kazumichi Kuroda; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

10.  TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation.

Authors:  Suryakant Niture; Maxwell A Gyamfi; Minghui Lin; Uchechukwu Chimeh; Xialan Dong; Weifan Zheng; John Moore; Deepak Kumar
Journal:  Cell Death Dis       Date:  2020-03-09       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.